open access

Online first
Short communication
Published online: 2023-02-28
Get Citation

Factors associated with terminal activation duration in young athletes

Zoran Šarčević12, Andreja Tepavčević
DOI: 10.33963/KP.a2023.0052
Pubmed: 36871298
  1. Novi Sad Health Care Center, Sports Medicine Center, Novi Sad, Serbia
  2. Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia

open access

Online first
Short communication
Published online: 2023-02-28


Not available


Not available
Get Citation
Supp./Additional Files (1)
Supplementary material
About this article

Factors associated with terminal activation duration in young athletes


Kardiologia Polska (Polish Heart Journal)


Online first

Article type

Short communication

Published online


Page views


Article views/downloads







Zoran Šarčević
Andreja Tepavčević

References (13)
  1. Basu J, Malhotra A. Interpreting the Athlete's ECG: Current State and Future Perspectives. Curr Treat Options Cardiovasc Med. 2018; 20(12): 104.
  2. McClean G, Riding NR, Ardern CL, et al. Electrical and structural adaptations of the paediatric athlete's heart: a systematic review with meta-analysis. Br J Sports Med. 2018; 52(4): 230.
  3. Li KaH, Bazoukis G, Liu T, et al. Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) in clinical practice. J Arrhythm. 2018; 34(1): 11–22.
  4. Ohno S. The genetic background of arrhythmogenic right ventricular cardiomyopathy. J Arrhythm. 2016; 32(5): 398–403.
  5. Sawant AC, Bhonsale A, te Riele AS, et al. Exercise has a disproportionate role in the pathogenesis of arrhythmogenic right ventricular dysplasia/cardiomyopathy in patients without desmosomal mutations. J Am Heart Assoc. 2014; 3(6): e001471.
  6. Zaidi A, Sheikh N, Jongman JK, et al. Clinical Differentiation Between Physiological Remodeling and Arrhythmogenic Right Ventricular Cardiomyopathy in Athletes With Marked Electrocardiographic Repolarization Anomalies. J Am Coll Cardiol. 2015; 65(25): 2702–2711.
  7. Hauer RNW, Cox MG, Groeneweg JA. Impact of new electrocardiographic criteria in arrhythmogenic cardiomyopathy. Front Physiol. 2012; 3: 352.
  8. Marcus FI, McKenna WJ, Sherrill D, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Circulation. 2010; 121(13): 1533–1541.
  9. Body mass index-for-age percentiles. Available online: /www cdc gov/growthcharts/data/set1clinical/cj41l023.pdf. [Accessed: April 7, 2022].
  10. Platonov PG, Calkins H, Hauer RN, et al. High interobserver variability in the assessment of epsilon waves: Implications for diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia. Heart Rhythm. 2016; 13(1): 208–216.
  11. De Lazzari M, Zorzi A, Cipriani A, et al. Relationship Between Electrocardiographic Findings and Cardiac Magnetic Resonance Phenotypes in Arrhythmogenic Cardiomyopathy. J Am Heart Assoc. 2018; 7(22): e009855.
  12. D'Ascenzi F, Pelliccia A, Valentini F, et al. Training-induced right ventricular remodelling in pre-adolescent endurance athletes: The athlete's heart in children. Int J Cardiol. 2017; 236: 270–275.
  13. Mast TP, Teske AJ, Te Riele AS, et al. Prolonged Electromechanical Interval Unmasks Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy in the Subclinical Stage. J Cardiovasc Electrophysiol. 2016; 27(3): 303–314.


Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73 , 80–180 Gdańsk, Poland

phone:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: